Fludarabine phosphate: a new active agent in hematologic malignancies.

Michael J. Keating; Susan O’Brien; William Plunkett; L. E. Robertson; Varsha Gandhi; Elihu H. Estey; Meletios A Dimopoulos; Fernando Cabanillas; A. Kemena; Hagop M. Kantarjian

Related publications

Article1993

New initiatives with fludarabine monophosphate in hematologic malignancies.

Michael J. Keating, Susan O’Brien, L. E. Robertson, Hagop M. Kantarjian, Meletios A Dimopoulos, Peter McLaughlin, Fernando Cabanillas, V. Grégoire, Liuqing Yang, Varsha Gandhi

Article1994

The Expanding Role of Fludarabine in Hematologic Malignancies

Michael J. Keating, Susan O’Brien, Lester E. Robertson, Hagop M. Kantarjian, Meletios A Dimopoulos, Peter McLaughlin, Fernando Cabanillas, V. Grégoire, Li Ying-Yang, Varsha Gandhi, Elihu H. Estey, William Plunkett

Article2020

Epitranscriptomics in Hematopoiesis and Hematologic Malignancies

Margalida Rosselló-Tortella, Gerardo Ferrer, Manel Esteller

Article2006

Targeting NF-κB in hematologic malignancies

Thomas Braun, G Carvalho, Claire Fabre, J. Grosjean, Pierre Fenaux, Guido Guido Kroemer

Article1997

Magnetic Resonance Imaging of the Bone Marrow in Hematologic Malignancies

Lia A. Moulopoulos, Meletios A Dimopoulos